Zoetis Inc
ZTS143.500USD
+2.400+1.70%
收盤 09/26, 16:00（美東）報價延遲15分鐘
63.71B總市值
24.39本益比TTM
關於 Zoetis Inc 公司
Zoetis Inc. 是一家全球性動物保健公司。該公司專注於藥物、疫苗、診斷產品和服務、生物設備、基因測試和精準動物保健的發現、開發、製造和商業化。該公司通過兩個部門運營：美國和國際部門。在每個運營部門中，該公司爲伴侶動物和牲畜客戶提供多樣化的產品組合，包括殺蟲劑、疫苗、皮膚病學、抗感染藥、止痛藥和鎮靜劑、其他藥物和動物健康診斷。該公司直接在北美、歐洲、非洲、亞洲、澳大利亞和南美洲的約 45 個國家/地區銷售其產品。該公司致力於將產品商業化，涉及八個核心物種：狗、貓和馬（統稱爲伴侶動物）以及牛、家禽、豬、魚和羊（統稱爲牲畜）。
公司簡介
公司代碼ZTS
公司名稱Zoetis Inc
上市日期Feb 01, 2013
CEOMs. Kristin C. Peck
員工數量13800
證券類型Ordinary Share
年結日Feb 01
公司地址10 Sylvan Way
城市PARSIPPANY
上市交易所NYSE Consolidated
國家United States of America
郵編07054
電話19738227000
網址https://www.zoetis.com/
公司代碼ZTS
上市日期Feb 01, 2013
CEOMs. Kristin C. Peck
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Mr. Robert J. Polzer, Ph.D.
Mr. Robert J. Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
2.82K
+51.75%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Parasiticides
562.00M
25.32%
Vaccines
447.00M
20.14%
Dermatology
390.00M
17.57%
Anti-infectives
249.00M
11.22%
Pain and sedation
210.00M
9.46%
其他
362.00M
16.31%
地區USD
名稱
營收
佔比
United States
1.18B
53.29%
Other emerging markets
248.00M
11.17%
Other Developed
133.00M
5.99%
Brazil
88.00M
3.96%
United Kingdom
77.00M
3.47%
其他
491.00M
22.12%
業務
地區
業務USD
名稱
營收
佔比
Parasiticides
562.00M
25.32%
Vaccines
447.00M
20.14%
Dermatology
390.00M
17.57%
Anti-infectives
249.00M
11.22%
Pain and sedation
210.00M
9.46%
其他
362.00M
16.31%
股東統計
更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.11%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.80%
Geode Capital Management, L.L.C.
2.50%
其他
74.73%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.11%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.80%
Geode Capital Management, L.L.C.
2.50%
其他
74.73%
股東類型
持股股東
佔比
Investment Advisor
49.46%
Investment Advisor/Hedge Fund
31.77%
Research Firm
5.03%
Insurance Company
3.90%
Bank and Trust
2.57%
Pension Fund
2.35%
Hedge Fund
2.17%
Sovereign Wealth Fund
1.25%
Family Office
0.15%
其他
1.36%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
2023Q1
2913
436.42M
94.33%
-5.14M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
41.36M
9.29%
+189.52K
+0.46%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
23.15M
5.2%
+208.71K
+0.91%
Mar 31, 2025
State Street Global Advisors (US)
19.80M
4.45%
-46.05K
-0.23%
Mar 31, 2025
State Farm Insurance Companies
16.88M
3.79%
-120.91K
-0.71%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.99M
2.47%
+368.11K
+3.47%
Mar 31, 2025
Wellington Management Company, LLP
6.07M
1.36%
-893.17K
-12.84%
Mar 31, 2025
Polen Capital Management, LLC
8.80M
1.98%
+1.31M
+17.55%
Mar 31, 2025
Wells Fargo Advisors
6.01M
1.35%
+338.64K
+5.97%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
5.06M
1.14%
+52.40K
+1.05%
Dec 31, 2024
查看更多
持股ETF
更新時間: 9月6日 週六
更新時間: 9月6日 週六
機構名稱
佔比
ProShares Pet Care ETF
9.75%
VanEck Agribusiness ETF
7.36%
VanEck Pharmaceutical ETF
6.02%
iShares U.S. Pharmaceuticals ETF
4.3%
SPDR S&P Pharmaceuticals ETF
3.89%
First Trust NASDAQ Pharmaceuticals ETF
3.78%
Honeytree US Equity ETF
3.55%
Polen Capital Global Growth ETF
3.35%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
3.16%
Jensen Quality Growth ETF
2.96%
查看更多
ProShares Pet Care ETF
佔比9.75%
VanEck Agribusiness ETF
佔比7.36%
VanEck Pharmaceutical ETF
佔比6.02%
iShares U.S. Pharmaceuticals ETF
佔比4.3%
SPDR S&P Pharmaceuticals ETF
佔比3.89%
First Trust NASDAQ Pharmaceuticals ETF
佔比3.78%
Honeytree US Equity ETF
佔比3.55%
Polen Capital Global Growth ETF
佔比3.35%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比3.16%
Jensen Quality Growth ETF
佔比2.96%
分紅派息
近5年累計派現
2.94B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
